Clinigen Group Plc (CLIGF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2021 | 06-2020 | 06-2019 | 06-2017 | 06-2016 | |
| Sales | 704,713 | 635,821 | 595,935 | 383,407 | 0 |
| Cost of Goods | 438,360 | 364,623 | 358,161 | N/A | N/A |
| Gross Profit | 266,354 | 271,198 | 237,774 | 383,407 | N/A |
| Operating Expenses | 183,940 | 218,868 | 206,110 | 0 | 0 |
| Operating Income | 82,773 | 52,954 | 31,825 | 383,407 | N/A |
| Interest Expense | 13,055 | 24,838 | 16,826 | 0 | 0 |
| Other Income | 0 | 378 | 1,044 | 0 | 0 |
| Pre-tax Income | 69,718 | 28,494 | 16,043 | 383,407 | 0 |
| Income Tax | 16,285 | 11,221 | 9,261 | N/A | N/A |
| Net Income Continuous | 53,432 | 17,273 | 6,782 | 55,679 | N/A |
| Net Income Discontinuous | -12,652 | N/A | N/A | 0 | N/A |
| Net Income | $40,781 | $17,273 | $6,782 | $4,820 | $N/A |
| EPS Basic Total Ops | 0.31 | 0.13 | 0.05 | 0.04 | N/A |
| EPS Basic Continuous Ops | 0.40 | 0.13 | 0.05 | 0.48 | N/A |
| EPS Basic Discontinuous Ops | -0.10 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | 0.30 | 0.13 | 0.05 | 0.04 | N/A |
| EPS Diluted Continuous Ops | 0.39 | 0.13 | 0.05 | 0.48 | N/A |
| EPS Diluted Discontinuous Ops | -0.09 | N/A | N/A | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | 0.83 | 0.81 | 0.69 | N/A | 0.47 |
| EBITDA(a) | $160,297 | $124,189 | $86,214 | $383,407 | $N/A |